TRICYCLIC COMPOUND AS ANTICANCER AGENTS

The present invention is directed to tricyclic compounds, pharmaceutically acceptable compositions comprising compounds of the invention and methods of using said compositions in the treatment of various disorders.

Saved in:
Bibliographic Details
Main Authors HAN, Wen-Ching, DEGNAN, Andrew P, LEE, Francis Y, DEBENEDETTO, Mikkel V, STARRETT, JR, John E, MANDAL, Sunil Kumar, GILL, Patrice, QUESNELLE, Claude A, SCHMITZ, William D, O'MALLEY, Daniel, HILL, Matthew D, GAVAI, Ashvinikumar V, TOKARSKI, John S, FANG, Haiquan, HUANG, Hong, VACCARO, Wayne, NORRIS, Derek J, DELUCCA, George V
Format Patent
LanguageEnglish
French
German
Published 23.12.2020
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention is directed to tricyclic compounds, pharmaceutically acceptable compositions comprising compounds of the invention and methods of using said compositions in the treatment of various disorders.
Bibliography:Application Number: EP20180192207